Total Payments
$480.88
2024 Payments
$177.27
Companies
6
Transactions
9
Medicare Patients
2,470
Medicare Billing
$158,763
Payment Breakdown by Category
Food & Beverage$480.88 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $480.88 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Haemonetics Corporation | $178.03 | 2 | $0 (2019) |
| Heron Therapeutics, Inc. | $144.07 | 2 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $59.00 | 1 | $0 (2024) |
| Beckman Coulter, Inc. | $39.45 | 2 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $37.80 | 1 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $22.53 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $177.27 | 3 | Heron Therapeutics, Inc. ($80.47) |
| 2022 | $86.13 | 2 | Heron Therapeutics, Inc. ($63.60) |
| 2020 | $11.17 | 1 | Beckman Coulter, Inc. ($11.17) |
| 2019 | $178.03 | 2 | Haemonetics Corporation ($178.03) |
| 2018 | $28.28 | 1 | Beckman Coulter, Inc. ($28.28) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | Cash or cash equivalent | $80.47 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 11/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $59.00 | General |
| 10/19/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $37.80 | General |
| Category: Pain Management | ||||||
| 11/04/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $63.60 | General |
| Category: Postoperative Pain | ||||||
| 09/06/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Migraine | ||||||
| 04/21/2020 | Beckman Coulter, Inc. | UNICEL DXI ACCESS (Device) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: IMMUNOASSAY | ||||||
| 10/10/2019 | Haemonetics Corporation | TEG (Device) | Food and Beverage | In-kind items and services | $91.00 | General |
| Category: Devices | ||||||
| 10/10/2019 | Haemonetics Corporation | TEG (Device) | Food and Beverage | In-kind items and services | $87.03 | General |
| Category: Devices | ||||||
| 12/18/2018 | Beckman Coulter, Inc. | UNICEL DXH (Device) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 121 | 173 | $23,646 | $7,053 |
| 2021 | 15 | 1,801 | 2,873 | $373,027 | $119,491 |
| 2020 | 10 | 548 | 792 | $101,280 | $32,219 |
Total Patients
2,470
Total Services
3,838
Medicare Billing
$158,763
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 77 | 120 | $16,550 | $4,312 | 26.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2022 | 18 | 25 | $4,335 | $1,821 | 42.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 15 | 15 | $1,809 | $751.04 | 41.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2022 | 11 | 13 | $952.00 | $168.74 | 17.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 810 | 1,370 | $192,826 | $49,831 | 25.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2021 | 144 | 229 | $45,555 | $20,510 | 45.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 104 | 336 | $42,880 | $16,160 | 37.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 223 | 278 | $30,826 | $11,659 | 37.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2021 | 31 | 93 | $9,125 | $4,930 | 54.0% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2021 | 148 | 156 | $12,180 | $2,971 | 24.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 46 | 91 | $5,795 | $2,801 | 48.3% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Office | 2021 | 19 | 19 | $4,617 | $2,309 | 50.0% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Office | 2021 | 43 | 44 | $7,480 | $2,274 | 30.4% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2021 | 77 | 82 | $7,470 | $1,925 | 25.8% |
| 85097 | Bone marrow, smear interpretation | Office | 2021 | 21 | 21 | $4,221 | $1,214 | 28.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2021 | 16 | 21 | $4,038 | $1,157 | 28.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Office | 2021 | 75 | 83 | $3,228 | $995.26 | 30.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 12 | 17 | $1,048 | $523.70 | 50.0% |
| 88302 | Pathology examination of tissue using a microscope | Office | 2021 | 32 | 33 | $1,738 | $229.98 | 13.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 265 | 416 | $58,324 | $16,017 | 27.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2020 | 59 | 81 | $14,415 | $6,104 | 42.3% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 30 | 75 | $9,685 | $4,046 | 41.8% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 53 | 57 | $6,439 | $2,683 | 41.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2020 | 59 | 62 | $4,739 | $1,032 | 21.8% |
| 88112 | Cell examination of specimen | Office | 2020 | 22 | 23 | $2,610 | $747.01 | 28.6% |
About Dr. David Hewitt, MD
Dr. David Hewitt, MD is a Cytopathology healthcare provider based in Visalia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124018148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hewitt, MD has received a total of $480.88 in payments from pharmaceutical and medical device companies, with $177.27 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($480.88).
As a Medicare-enrolled provider, Hewitt has provided services to 2,470 Medicare beneficiaries, totaling 3,838 services with total Medicare billing of $158,763. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Cytopathology
- Other Specialties Forensic Pathology, Hematology
- Location Visalia, CA
- Active Since 10/21/2005
- Last Updated 02/06/2008
- Taxonomy Code 207ZC0500X
- Entity Type Individual
- NPI Number 1124018148
Products in Payments
- TEG (Device) $178.03
- ZYNRELEF (Drug) $80.47
- Zynrelef (Drug) $63.60
- Exparel (Drug) $37.80
- UNICEL DXH (Device) $28.28
- Trudhesa (Drug) $22.53
- UNICEL DXI ACCESS (Device) $11.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.